Vivien Diniz

vdiniz@resourceinvestingnews.com

Articles

Do Generic Drugs Make the Cut?

Once a drug patent expires, a generic drug company can manufacture a generic bioequivalent. What does that mean for consumers?...

October 31st, 2016

What Does Gene Editing Mean for the Future?

Researchers at the University of California in San Diego have found a way to use gene editing technology to target...

October 27th, 2016
October 11th, 2016

Can Nanotechnology Mend Your Broken Heart?

Advancements in nanotechnology in medicine are able to help treat, repair and possibly even prevent heart attacks or other heart-related...

June 13th, 2016

Israel: A Medical Device Powerhouse?

A look at Israel's medical device sector.

May 12th, 2016

Is Gold Entering a Bull Market?

Are we finally seeing a gold bull run?

May 11th, 2016

Medical Nanotechnology: 3 Areas of Research

Advancements in medical nanotechnology are forcing doctors and scientists to look at different ways to treat patients and gather insight...

May 11th, 2016

What are the 5 Top Holdings in the SPDR S&P Biotechnology ETF?

Which companies have the heaviest weight in the SPDR S&P Biotechnology ETF

May 10th, 2016

5 Top NASDAQ Biotech Stocks: Sophiris Bio up 30 Percent

Sarepta Therapeutics. Echo Therapeutics, Heska Corp, and Cyclacel Pharmaceuticals were also the week's top gainers.

May 8th, 2016

5 Top Holdings in the Global X Uranium ETF

What to know which companies make up the top five in the Globe X Uranium ETF?

May 5th, 2016